References
- Sanders LJ. Jean-Martin Charcot (1825–1893). The man behind the joint disease. Journal of the American Podiatric Medicine Association 2002; 92(7): 375–380
- Nozawa S, Miyamoto K, Nishimoto H, Sakaguchi Y, Hosoe H, Shimizu K. Charcot joint in the elbow associated with syringomyelia. Orthopedics 2003; 26: 731–732
- Crispin JC. Rheumatologic manifestations of diabetes mellitus. American Journal of Medicine 2003; 114: 753–757
- Bar-On E. Congenital insensitivity to pain. Orthopaedic manifestations. Journal of Bone & Joint Surgery–British volume 2002; 84: 252–257
- Selmi F. Charcot joint of the spine, a cause of autonomic dysreflexia in spinal cord injured patients. Spinal Cord 2002; 40: 481–483
- Lokiec F, Arbel R, Isakov J, Wientroub S. Neuropathic arthropathy of the knee associated with an intra-articular neurofibroma in a child. [Case Reports. Journal Article] Journal of Bone & Joint Surgery—British volume 1998; 80: 468–470
- Nagarkatti DG, Banta J, Thomson J. Charcot arthropathy in spina bifida. Journal of Pediatric Orthopaedics 2000; 20: 82–87
- Brower A, Allman R. Pathogenesis of the neurotrophic joint: Neurotraumatic vs. neurovascular. Radiology 1981; 139: 349–354
- Deirmengian C, Lee SG, Jupiter J. Neuropahtic arhtropathy of the elbow. A report of five cases. Journal of Bone & Joint Surgery 2001; 83-A: 839–844
- McGill M, Molyneaux L, Bolton T, Ioannou K, Uren R, Yue DK. Response of Charcot's arthropathy to contact casting: Assessment by quantitative techniques. Diabetologia 2000; 43: 481–484
- Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL. Arthrodesis as an early alternative to nonoperative management of charcot arthropathy of the diabetic foot. Journal of Bone and Joint Surgery–American volume 2000; 82-A: 939–950
- Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, Foster AV, Edmonds ME, Boulton AJ. Bisphosphonates in the treatment of Charcot neuroarthropathy: A double-blind randomized controlled trial. Diabetologia 2001; 44: 2032–2037
- Rauch F. Osteogenesis imperfecta types I, III, and IV: Effect of pamidronate therapy on bone and mineral metabolism. Journal of Clinical Endocrinology and Metabolism 2003; 88: 986–992
- Langman C, Abt I. Improvement of bone in patients with osteogenesis imperfecta treated with pamidronate—lessons from biochemistry. Journal of Clinical Endocrinology and Metabolism 2003; 88: 984–985
- Henderson RC, Lark R, Kecskemethy H, Miller F, Harcke HT, Bachrach S. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: A randomized, placebo-controlled clinical trial. Journal of Pediatrics 2002; 141: 644–651